Market Trends of Asia-Pacific Ultrasound Devices Industry
This section covers the major market trends shaping the APAC Ultrasound Devices Market according to our research experts:
3D and 4D Ultrasound Imaging Segment is Expected to Witness a Significant Growth Over the Forecast Period.
3D ultrasound imaging has the potential to provide real-time imaging of the anatomical structure. Real-time 3D ultrasound has more advantages for guiding interventional procedures. These devices can visualize real-time tissue organs in 3D, while a 4D ultrasound is like a 3D ultrasound except that the image it generates is continuously updated, much like a moving image. The 3D and 4D ultrasound imaging are expected to witness significant growth over the forecast period, owing to the extensive technological advancements in the development of 3D and 4D ultrasound devices, favorable reimbursements, a wide range of applications, and added advantages of the devices, such as high definition (HD) motion and 3D and 4D visualizations.
New product launches by key market players are also fueling the market in the Asia-Pacific region. For instance, in June 2022, Mindray launched a new ultrasound product to address the unique demands of busy obstetrics and gynecology (OB/GYN) practices, the Imagyn I9 Ultrasound Machine. The Imagyn I9 Ultrasound System is Mindray's first dedicated obstetrics and gynecology (OB/GYN) product slated to meet the rigorous demands of its practices. Also, the use of real-time 3D/4D or echocardiography technology to evaluate a patient's cardiac condition is propelling the growth of this segment due to the high incidence of cardiovascular disease (CVDs) reported in many countries of the Asia-Pacific region. For instance, an article titled, 'Cardiovascular disease (CVD) and its associated risk factors among older adults in India: Evidence from LASI Wave 1' published in February 2022 reported that the overall self-reported prevalence of diagnosed cardiovascular disease prevalence (CVDs) was 29.4% for older adults aged 45 and above in 2020 in India. Thus, due to the aforesaid mentioned reasons, the segment is expected to witness significant growth over the forecast period, thereby fueling the growth of the studied market.
China is Expected to Witness Significant Growth Over the Studied Forecast Period.
China is expected to witness significant growth over the forecast period due to technological advancement, key market players, the increase in the aging population, and the rise in cases of cancer. Ultrasound devices provide clear pictures of some soft tissue diseases and it is a good way to detect fluid-filled cysts from solid tumors because they make very different echo patterns. It's useful in some situations because it can usually be done quickly and doesn't expose people to radiation. Thus, it can also help to detect cancers. The increasing incidence of cancer cases in China is fueling the growth of this market. For instance, the 2021 Globocan database reported 4.57 million cancer cases in the region, and this number is expected to increase up to 6.85 million by 2040, thus fueling the growth of the studied market. Also, the increasing geriatric population in the region is expected to drive the market as they are more susceptible to chronic diseases or more prone to chronic diseases.
Also, various applications and research of ultrasound imaging in the diagnosis of different diseases are fueling the growth of the studied market in China. For instance, an article titled, 'Lung ultrasound completely replaced chest X-ray for diagnosing neonatal lung diseases: a 3-year clinical practice report from a neonatal intensive care unit in China' published in August 2020 reported that lung ultrasound (LUS) has been widely used in the diagnosis and differential diagnosis of neonatal lung diseases (NCDs), but whether it can replace the routine use of chest X-ray (CXR) in neonatal intensive care units (NICUs). Another clinical study, approved by the Ethics Committee of Huoshenshan Hospital, Wuhan, China published in July 2021, in the article, 'Quantitative Analysis and Automated Lung Ultrasound Scoring for Evaluating COVID-19 Pneumonia With Neural Networks' reported that ultrasonography plays an important role in diagnosing and evaluating COVID-19 pneumonia (PN) in this epidemic. The lung ultrasound scores and lung ultrasound (LUS) were used to estimate the excessive lung fluid that is an important clinical manifestation of COVID-19 pneumonia (PN), with high sensitivity and specificity. Thus, due to the aforesaid mentioned reasons the region is expected to show significant growth over the forecast period, thereby driving the market.
